Introduction {#s1}
============

Electroconvulsive therapy (ECT) remains the most effective approach for treatment resistant depressive episodes, as well as the most established neuromodulation technique ([@bib69]; [@bib21]). Despite intensive research, however, the mechanism of action for ECT remains unknown, but does involve at least two potentially therapeutic components: electric perturbation and/or seizure activity. One common element across various neuromodulation techniques is the application of different intensities of electric field (EF) on the human brain. Understanding how ECT-induced EF interacts with the cortex and subcortical structures can both advance our mechanistic understanding of ECT and enrich our understanding of other neuromodulation approaches such as magnetic seizure therapy (MST), transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS).

A recent longitudinal ECT-imaging study from the Global ECT-MRI Collaboration (GEMRIC) ([@bib49]) assessed hippocampal volume changes in a large cohort of subjects (N = 268) receiving right unilateral (RUL) or bilateral (BL) electrode placements. The results demonstrated that the volume of the hippocampus increased over the course of ECT treatment and correlated with the number of ECT sessions administered during the ECT series. In addition, the subjects receiving RUL electrode placement had a significantly larger volume change ipsilateral to the side of stimulation, consistent with previous ECT-neuroimaging observations ([@bib1]; [@bib19]; [@bib52]; [@bib10]; [@bib58]; [@bib13]). Our most recent study of 331 subjects with longitudinal MRI scanning pre- and post-ECT showed brain volume increases across several subcortical and cortical regions with strong lateralization of the effects if the electrode placement was RUL ([@bib50]). Contrary to a priori expectations ([@bib33]; [@bib12]), increased volume in these key areas did not translate to better clinical outcome. While the association between the number of ECT sessions and volume change and the laterality of the volume changes all implied a dose--response causative relationship, the role of ECT-mediated neuroplasticity and the underlying mechanism for antidepressant response remains elusive. Furthermore, given the naturalistic design of the studies included for mega-analysis (e.g., non-responders had a longer ECT course and were frequently switched to bilateral treatment at varying intervals), both the number of ECT sessions and electrode placement varied depending on the clinical response, further confounding the dose-response association and its interpretation.

Recent research has challenged the notion that a primary purpose of electric stimulation in treating depression is to generate widespread seizure activity ([@bib57]; [@bib54]). Alternatively, electric stimulation may be a therapeutic component of ECT and similar to other non-convulsive neuromodulation treatments. Finite-element simulation was developed to estimate the spatial distribution of the electric field on a voxel-wise basis ([@bib40]; [@bib6]). The technique was recently validated in humans ([@bib30]). Preliminary computational analyses based on three realistic head models suggested that the ECT electric field distribution had a direct association with clinical and cognitive outcomes, explaining the rationale behind different electrode placement strategies in ECT treatment ([@bib4]). This finding is in agreement with our previous observation where RUL treatment induced higher volumetric changes in the right hippocampus compared to the left ([@bib49]), implying that more lateralized electric stimulation rather than a global generalized seizure, may be responsible at least for part of the antidepressant effects of ECT. However, to date, no study has demonstrated the relationship between ECT electric field distribution and treatment response. In this study, we used the large Global ECT-MRI Research Collaboration (GEMRIC) ECT-imaging data set to explicitly determine the relationships between regional 1) electric field strength and volume changes, 2) volume changes and antidepressant response, and 3) electric field and antidepressant response. For the purpose of our primary research question and in contrast to previous GEMRIC investigations, we limited the analyses to subjects that only received right unilateral electrode placement.

Results {#s2}
=======

Clinical results {#s2-1}
----------------

Subjects showed an average MADRS improvement of 61.3%±33.9% following ECT (pre-ECT MADRS 33.9 (range: 14--54), post-ECT MADRS 12.9 (range: 0--51). Highly significant correlations between age and clinical response (t = 5.75, df = 149, r = 0.43, p\<10^−7^, older patients responded better), as well as age and total brain volume (t = −7.32, df = 149, r = −0.51, p\<10^−10^) were also observed.

Laterality of electric field and volume change {#s2-2}
----------------------------------------------

ECT was associated with increased volume across all brain regions except the brain stem and bilateral cerebellum cortex ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). In the majority of the regions, right hemisphere regions had greater volumetric change with respect to the corresponding left hemisphere region; no left hemipshere regions had greater volumetric changes compared to the corresponding right-sided region ([Supplementary file 2](#supp2){ref-type="supplementary-material"}, [Figure 1](#fig1){ref-type="fig"}). Average EF strongly correlated with ∆Vol across the ROIs ([Figure 1](#fig1){ref-type="fig"}, t = 3.77, df = 83, r = 0.38, p=0.0003). To show that this correlation was not simply due to a general effect of the hemisphere (right side had higher EF and volume change while left side had lower values), we calculated laterality indices in both EF and volume change. The correlation between laterality indices for EF and ∆Vol also had a positive relationship ([Figure 2](#fig2){ref-type="fig"}, t = 2.13, df = 40, r = 0.32, p=0.04) across 42 regions (brain stem is missing, since it is not a bilateral structure).

![Electric Field (EF) and volume change across 85 brain regions.\
Upper panel first row: Mean EF across 85 brain regions; second row: the effect size of volume changes between baseline and at the end of the course of ECT across 85 regions. Lower panel, left: Effect sizes of right unilateral stimulations were consistently higher on the right side than on the left side. Lower panel, right: Scatter plot of regional EF versus regional volume change (r = 0.38; p \<0.001; df = 83; t = 3.77). (d) = Cohen's d effect size..\
Figure 1---source data 1.Mean electric field and volume change in 85 brain regions.](elife-49115-fig1){#fig1}

![Laterality differences in EF and ∆vol (upper panel) as well as the relationship between laterality between EF/∆vol (lower panel).\
Regression line indicates the correlation between laterality indices of EF and volume change (r = 0.32; p\<0.05; df = 40; t = 2.13).\
Figure 2---source data 1.Mean electric field and volume change asymteries in corresponding 42 brain regions.](elife-49115-fig2){#fig2}

Electric field and volume change {#s2-3}
--------------------------------

In a multiple regression analysis controlled for age, number of ECT sessions and site, we found that left hippocampus and left amygdala had a strong relationship with EF in these regions (FDR corrected p\<0.01, [Table 1](#table1){ref-type="table"}). Post hoc analyses of the hippocampus ([Figure 3](#fig3){ref-type="fig"}) and amygdala ([Figure 4](#fig4){ref-type="fig"}) illustrate that the relationship between EF and ∆Vol was dose-dependent and scaled across the hemispheres (hippocampus: t = 5.97, df = 300, r = 0.3259, p\<0.0001; amygdala: t = 11.3538, df = 300, r = 0.5482, p\<0.0001). Age was a necessary covariate since it was a confound in our model: both the spatial distribution of EF and volume changes correlate with age ([@bib16]). We add number of ECT as a covariate to the model to be able to compare the relative influence of EF and number of ECT on volume change. In both left hippocampus and amygdala the effect size of EF was the largest (hippocampus: t~EF~ = 4.5, t~Age~ = −2.7, t~ECTnum~ = 3.3, amygdala: t~EF~ = 3.9, t~Age~ = −1.1, t~ECTnum~ = 2.1; [Table 1](#table1){ref-type="table"}).

![Individual specific relationship between EF and volume change in the hippocampus.\
Left: Scatterplot of EF versus volume change in the hippocampus (t = 5.97, df = 300, r = 0.33, p \< 0.0001, left and right side together). There is a significant relationship on the left side (orange dots; t = 4.53, df = 149, r = 0.35, p \< 0.0001), but not on the right side (probably due to ceiling effect) (t = 1.59, df = 149, r = 0.13, p = 0.11). Right: The difference in right and left hippocampal volume changes is significant (t = 7.76, df = 150, mean difference = 0.011, p \< 0.0001).\
Figure 3---source data 1.Left and right hippocampal EF and volume change in 151 individual.](elife-49115-fig3){#fig3}

![Individual specific relationship between EF and volume change in the amygdala.\
Left: Scatterplot of EF versus volume change in the amygdala (t = 11.35, df = 300, r = 0.55, p\<0.0001; left and right side together). Both the left (orange dots) and right (blue dots) hemisphere shows highly significant relationships (t = 4.01, df = 149, r = 0.31, p=0.0001; and t = 4.02, df = 149, r = 0.31, p=0.0001). Right: The difference in right and left amygdala volume changes is significant (t = 13.58, df = 150, mean difference = 0.029, p\<0.0001).\
Figure 4---source data 1.Left and right amygdala EF and volume change in 151 individual.](elife-49115-fig4){#fig4}

###### The relationship between volume changes and EF across individuals (Δ Vol \~ EF + Age + ECTnum).

       roi                                      t~EF~     p~EF~    t~Age~    t~ECTnum~   BH^EF^~FDR~
  ---- ---------------------------------------- --------- -------- --------- ----------- -------------
  1    Δ VOL~Left.Cerebellum.Cortex~            −0.3668   0.7143   −0.1150   1.9368      0.8205
  2    Δ VOL~Left.Thalamus.Proper~              0.0244    0.9805   −0.4046   2.8696      0.9952
  3    Δ VOL~Left.Caudate~                      0.6555    0.5132   −0.8301   2.6428      0.6924
  4    Δ VOL~Left.Putamen~                      0.5737    0.5671   −0.5992   1.3203      0.7212
  5    Δ VOL~Left.Pallidum~                     0.0060    0.9952   0.1026    1.2295      0.9952
  6    Δ VOL~Brain.Stem~                        1.2114    0.2278   0.8536    1.2309      0.4466
  7    Δ VOL~Left.Hippocampus~                  4.5102    0.0000   −2.6814   3.3221      0.0012
  8    Δ VOL~Left.Amygdala~                     3.9069    0.0001   −1.0572   2.1018      0.0061
  9    Δ VOL~Left.Accumbens.area~               2.0238    0.0449   −3.4456   1.7246      0.1737
  10   Δ VOL~Left.VentralDC~                    0.1740    0.8621   0.0605    2.2614      0.9395
  11   Δ VOL~Right.Cerebellum.Cortex~           −0.5564   0.5788   0.0677    1.3212      0.7235
  12   Δ VOL~Right.Thalamus.Proper~             0.4582    0.6475   0.3541    4.0787      0.7712
  13   Δ VOL~Right.Caudate~                     1.2293    0.2210   1.0254    1.5097      0.4466
  14   Δ VOL~Right.Putamen~                     1.0724    0.2854   −0.5112   1.4987      0.4756
  15   Δ VOL~Right.Pallidum~                    0.6045    0.5465   0.8016    2.9589      0.7181
  16   Δ VOL~Right.Hippocampus~                 1.5090    0.1336   −1.2924   3.2473      0.3441
  17   Δ VOL~Right.Amygdala~                    2.9945    0.0032   −0.6087   4.2603      0.0344
  18   Δ VOL~Right.Accumbens.area~              1.9563    0.0524   −0.8782   3.5228      0.1937
  19   Δ VOL~Right.VentralDC~                   0.3488    0.7278   0.5197    0.7438      0.8248
  20   Δ VOL~ctx.lh.bankssts~                   1.1757    0.2417   −0.4102   2.5801      0.4466
  21   Δ VOL~ctx.lh.caudalanteriorcingulate~    1.3404    0.1823   −1.2881   2.2330      0.4254
  22   Δ VOL~ctx.lh.caudalmiddlefrontal~        −1.8989   0.0596   −0.3804   2.0087      0.2112
  23   Δ VOL~ctx.lh.cuneus~                     0.9827    0.3274   0.1037    2.0348      0.5352
  24   Δ VOL~ctx.lh.entorhinal~                 3.2229    0.0016   −1.2447   1.6659      0.0335
  25   Δ VOL~ctx.lh.fusiform~                   3.0717    0.0026   −0.1806   2.1319      0.0344
  26   Δ VOL~ctx.lh.inferiorparietal~           1.5131    0.1325   0.8515    2.3077      0.3441
  27   Δ VOL~ctx.lh.inferiortemporal~           2.6985    0.0078   0.6415    1.9131      0.0577
  28   Δ VOL~ctx.lh.isthmuscingulate~           −0.3275   0.7438   −0.4344   2.9060      0.8319
  29   Δ VOL~ctx.lh.lateraloccipital~           1.1916    0.2354   0.3669    1.2752      0.4466
  30   Δ VOL~ctx.lh.lateralorbitofrontal~       1.4274    0.1557   −0.0081   1.5758      0.3780
  31   Δ VOL~ctx.lh.lingual~                    0.1391    0.8896   0.3506    2.4745      0.9572
  32   Δ VOL~ctx.lh.medialorbitofrontal~        1.0744    0.2845   −0.1246   1.1852      0.4756
  33   Δ VOL~ctx.lh.middletemporal~             2.0679    0.0405   −0.3780   2.2600      0.1720
  34   Δ VOL~ctx.lh.parahippocampal~            1.2683    0.2068   −0.2446   2.8373      0.4466
  35   Δ VOL~ctx.lh.paracentral~                −2.0829   0.0391   0.2511    4.0937      0.1720
  36   Δ VOL~ctx.lh.parsopercularis~            −0.6949   0.4883   −0.7822   1.8435      0.6694
  37   Δ VOL~ctx.lh.parsorbitalis~              0.8057    0.4218   −1.0427   0.9524      0.6289
  38   Δ VOL~ctx.lh.parstriangularis~           0.8228    0.4120   −1.2157   2.7977      0.6254
  39   Δ VOL~ctx.lh.pericalcarine~              0.4426    0.6587   −0.0479   1.8463      0.7712
  40   Δ VOL~ctx.lh.postcentral~                0.8692    0.3862   −1.7655   2.5145      0.5969
  41   Δ VOL~ctx.lh.posteriorcingulate~         −0.8698   0.3859   −0.6961   3.3193      0.5969
  42   Δ VOL~ctx.lh.precentral~                 −0.7279   0.4679   −1.2884   2.4234      0.6682
  43   Δ VOL~ctx.lh.precuneus~                  −1.5879   0.1145   −0.4353   3.6729      0.3441
  44   Δ VOL~ctx.lh.rostralanteriorcingulate~   1.3315    0.1852   −0.4449   0.5630      0.4254
  45   Δ VOL~ctx.lh.rostralmiddlefrontal~       −0.7192   0.4732   −1.6205   1.1936      0.6682
  46   Δ VOL~ctx.lh.superiorfrontal~            −1.2073   0.2293   −0.5851   2.1065      0.4466
  47   Δ VOL~ctx.lh.superiorparietal~           −1.7423   0.0836   0.6952    3.3288      0.2734
  48   Δ VOL~ctx.lh.superiortemporal~           2.2820    0.0240   −2.0868   1.6393      0.1199
  49   Δ VOL~ctx.lh.supramarginal~              0.5717    0.5685   −0.2467   2.1282      0.7212
  50   Δ VOL~ctx.lh.frontalpole~                −0.2029   0.8395   −0.2904   0.4776      0.9267
  51   Δ VOL~ctx.lh.temporalpole~               2.5288    0.0125   −0.0731   1.3167      0.0762
  52   Δ VOL~ctx.lh.transversetemporal~         0.4387    0.6616   −0.4617   2.1817      0.7712
  53   Δ VOL~ctx.rh.bankssts~                   0.1121    0.9109   2.0777    2.9991      0.9678
  54   Δ VOL~ctx.rh.caudalanteriorcingulate~    −1.4295   0.1551   1.2935    2.4016      0.3780
  55   Δ VOL~ctx.rh.caudalmiddlefrontal~        −2.9569   0.0036   1.6943    2.6065      0.0344
  56   Δ VOL~ctx.rh.cuneus~                     −0.0087   0.9930   −1.1806   2.4017      0.9952
  57   Δ VOL~ctx.rh.entorhinal~                 1.2514    0.2129   0.7897    2.4722      0.4466
  58   Δ VOL~ctx.rh.fusiform~                   1.5380    0.1263   0.7997    4.7854      0.3441
  59   Δ VOL~ctx.rh.inferiorparietal~           −2.9902   0.0033   1.6520    0.7114      0.0344
  60   Δ VOL~ctx.rh.inferiortemporal~           0.9300    0.3540   1.9310    3.3455      0.5677
  61   Δ VOL~ctx.rh.isthmuscingulate~           0.0325    0.9741   0.4230    1.1493      0.9952
  62   Δ VOL~ctx.rh.lateraloccipital~           1.1796    0.2401   0.6095    1.5161      0.4466
  63   Δ VOL~ctx.rh.lateralorbitofrontal~       0.5347    0.5937   0.3393    2.9240      0.7314
  64   Δ VOL~ctx.rh.lingual~                    −0.0753   0.9401   −1.9555   3.5258      0.9865
  65   Δ VOL~ctx.rh.medialorbitofrontal~        0.7090    0.4795   1.5479    2.3419      0.6682
  66   Δ VOL~ctx.rh.middletemporal~             −0.6005   0.5492   2.1275    3.6781      0.7181
  67   Δ VOL~ctx.rh.parahippocampal~            1.5217    0.1303   0.5057    3.1874      0.3441
  68   Δ VOL~ctx.rh.paracentral~                −3.5101   0.0006   2.1809    2.2718      0.0170
  69   Δ VOL~ctx.rh.parsopercularis~            −2.5585   0.0116   2.8854    2.9459      0.0756
  70   Δ VOL~ctx.rh.parsorbitalis~              1.0872    0.2788   −0.5812   2.3737      0.4756
  71   Δ VOL~ctx.rh.parstriangularis~           −1.2468   0.2146   1.0686    2.6086      0.4466
  72   Δ VOL~ctx.rh.pericalcarine~              1.5878    0.1146   −0.0096   2.2815      0.3441
  73   Δ VOL~ctx.rh.postcentral~                −1.7565   0.0812   1.2943    3.0605      0.2734
  74   Δ VOL~ctx.rh.posteriorcingulate~         −1.5171   0.1315   2.0716    1.4731      0.3441
  75   Δ VOL~ctx.rh.precentral~                 −2.4918   0.0139   0.9967    3.7013      0.0762
  76   Δ VOL~ctx.rh.precuneus~                  −2.0231   0.0450   −0.1921   2.5419      0.1737
  77   Δ VOL~ctx.rh.rostralanteriorcingulate~   2.2083    0.0288   1.3734    2.3606      0.1362
  78   Δ VOL~ctx.rh.rostralmiddlefrontal~       −2.6842   0.0081   0.5804    2.2235      0.0577
  79   Δ VOL~ctx.rh.superiorfrontal~            −3.0013   0.0032   1.1011    3.2699      0.0344
  80   Δ VOL~ctx.rh.superiorparietal~           −2.7495   0.0067   0.9014    2.0779      0.0574
  81   Δ VOL~ctx.rh.superiortemporal~           0.4377    0.6623   1.2455    4.4002      0.7712
  82   Δ VOL~ctx.rh.supramarginal~              −2.4794   0.0143   2.7408    3.0429      0.0762
  83   Δ VOL~ctx.rh.frontalpole~                1.1256    0.2623   −0.1784   1.9185      0.4644
  84   Δ VOL~ctx.rh.temporalpole~               0.7274    0.4682   0.5099    3.7696      0.6682
  85   Δ VOL~ctx.rh.transversetemporal~         1.1426    0.2551   0.6448    3.2405      0.4614

We also investigated the spatial specificity of these correlations. First, we permutated the regional labels in the volumetric changes across all possible ROIs and calculated the correlations between the EF and ∆Vol. The correlation between EF and the corresponding ∆Vol ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}, left panels, indicated with red dot) was always in the top 5% among all possible correlations. Second, we permutated the region labels in the EF across all possible ROIs and calculated the correlations between the EF and ∆Vol ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} right panels). Overall these results indicate a strong spatial selectivity in the relationship between EF and ∆Vol.

Electric field, volume change, and clinical response {#s2-4}
----------------------------------------------------

We further investigated if EF directly or indirectly (mediated via volume change) leads to clinical response. In a multiple regression analysis, we tested if volumetric changes controlled for age, number of ECT sessions, and site had an effect on clinical response measured by MADRS changes. Results indicated that none of the volume changes across the 85 ROIs had a significant relationship with clinical response ([Supplementary file 3](#supp3){ref-type="supplementary-material"}, hippocampus: t~ΔVOL~ = 0.2, t~Age~ = 5.4, t~ECTnum~ = −2.7, amygdala: t~ΔVOL~ = 0.1, t~Age~ = 5.6, t~ECTnum~ = −3.0). These results therefore contradicted the hypothesis that EF by increasing brain volume indirectly exerts its effect on clinical response, given the negative results between the volume change (mediator) and MADRS change (outcome). Testing the direct effect of the EF, we failed to find significant correlations between EF and clinical response ([Supplementary file 4](#supp4){ref-type="supplementary-material"}, hippocampus: t~EF~ = 1.2, t~Age~ = 5.7, t~ECTnum~ = −3.0, amygdala: t~EF~ = 1.1, t~Age~ = 5.7, t~ECTnum~ = −3.0). Similar to earlier studies, age strongly correlated with both clinical response ([@bib25]; [@bib47]), also see *Clinical Results*) and EF distribution ([@bib16]), therefore we controlled for age in our model. The rationale for including the number of ECT treatments as covariate needs more explanation. Due to the naturalistic nature of the design, where most sites followed the patient until response or site-determined criteria for ECT discontinuation, we observed a negative relationship between clinical response and the number of ECT treatments. Not controlling for this variable could lead to spurious correlation between volume change and clinical response (for more on this see [@bib49]). In a post-hoc analysis, we also examined the interaction between EF and volume change in relation to clinical outcome (excluding age as a covariate), but we again failed to find significant effects for any region. To explore further, we investigated if changing age to baseline volume in the mixed model would modify results, but we did not find significant effects (age and baseline volume correlates strongly across almost all regions -- [Supplementary file 5](#supp5){ref-type="supplementary-material"}).

Discussion {#s3}
==========

This study investigated the relationship between electric field, volume change and clinical response to ECT. We used a large sample of subjects with depression receiving ECT with right unilateral electrode placement from the GEMRIC database. The key findings included a lateralization (right \>left) of the electric field and changes in regional brain volume in association with ECT. The use of right unilateral electrode placement, which elicits greater right hemisphere electric fields, can thus be dissociated from generalized seizure activity such that their contributions to antidepressant mechanisms may be at least partially distinct. Further, regional volume increase and electric field distributions were strongly related, especially in the left hippocampus and left amygdala. Here, the observed relationships between electric field and volume change suggest that a minimum electric field of 30--40 V/m is necessary for subsequent changes in brain structure, and that EF may have a 'ceiling effect' above approximately 100 V/m as illustrated for right hippocampal volume (see [Figure 3](#fig3){ref-type="fig"}). However, volume change and electric field were not statistically related to clinical response after controlling for age, number of ECT sessions and site. Below, we discuss potential mechanisms for electric field and volume change that may be considered both independent and synergistic with seizure activity. We also discuss potential future directions to elucidate the role of electric field distributions with clinical response.

The biological underpinnings of ECT-mediated volume change ([@bib49]; [@bib50]) could be related to seizure activity, cerebral blood flow, electric field strength, or synergy between the generalized seizure and electric field (e.g. the electric field determines site and focality of seizure initiation, which can subsequently affect seizure propagation and termination). Several neuroplastic mechanisms including neurogenesis, angiogenesis, synaptogenesis, gliogenesis may be specific to the rapidly changing electric field ([@bib9]; [@bib68]). Although heavily debated ([@bib63]; [@bib7]; [@bib3]), the support for adult neurogenesis is based on pre-clinical studies demonstrating neuronal division and differentiation related to suprathreshold electric stimulation ([@bib60]; [@bib41]; [@bib51]; [@bib61]). However, neurogenesis as the sole mechanism of neuroplasticity may be incompatible with the time frame and expansive volume change. Specifically, the ECT series is less than one month in duration, but pre-translational investigations have established that adult neurogenesis may take up to six months ([@bib35]). Furthermore, adult neurogenesis is limited to the hippocampus and olfactory bulb and does not support the volume change in 82 out of 85 regions demonstrated in our investigation ([@bib37]). Alternatively, volume change may be related to fluid shifts due to vascularization ([@bib26]), blood flow changes ([@bib43]; [@bib39]) and inflammation ([@bib72]; [@bib31]; [@bib23]; [@bib70]; [@bib73]). Vasogenic edema secondary to the hypertensive surge commonly associated with electroconvulsive stimulation and possible breach of the blood brain barrier could be a potentially iatrogenic mechanism of volumetric increase, but the available pre-clinical and ECT-imaging studies (focused on T2 relaxtion time) so far have produced mixed results ([@bib2]; [@bib38]; [@bib8]; [@bib45]; [@bib66]). The generalized seizure and global changes in blood flow would not explain the laterality of volumetric changes (right \>left) ipsilateral to the hemisphere of stimulation as seen in our current and previous investigations ([@bib1]; [@bib19]; [@bib52]; [@bib10]; [@bib58]; [@bib13]). The laterality with electric field and volume change suggest a mechanistic role of the electric field that may be independent or synergistic with seizure generation. Pre-translational investigations have demonstrated that increased stimulus charge increased dendritic arborization in a dose-related fashion ([@bib62]). Furthermore, the behavioral improvement after electroconvulsive stimulation are related to increased dendritic complexity, synaptic remodeling, and neuronal survival ([@bib32]). However, additional pre-clinical studies are clearly needed to resolve the mechanistic link between electric field and neuroplasticity.

Our original hypothesis was that a) local electric field had a causal role in clinical outcome and that b) the corresponding volume change was mediating this relationship. In order to support this model, data analysis should have indicated 1) a significant correlation between volume change and electric field, 2) a significant correlation between clinical outcome and volume change, and 3) that only the effect of volume change is significant in a multilinear regression model when both electric field and volume change is added as covariates (outcome \~volume change + electric field). However, since volume change showed no correlation with clinical change, neither in this dataset, nor in the recently published broader dataset with more heterogeneous ECT electrode placement ([@bib50]), only the first half of this model, namely that electric field strength was associated with volume change, was supported by our data.

The null relationship between electric field, volume change and clinical outcome may be attributed to demographic (age) and other treatment related factors (number of sessions, rate of response). For example, age-related structural brain changes may mediate these relationships and thus were an important consideration in our analysis. Our results are consistent with previous ECT investigations demonstrating that older patients often have higher response rates ([@bib47]; [@bib46]; [@bib11]). Previous electric field modeling investigations have demonstrated that age-related structural brain changes modulate the spatial distribution of the calculated electric field ([@bib14]). However, when including age in the assessment with electric field, volume change and clinical outcome, our results suggest more complex or alternative mechanisms underlie differential age-related response to ECT.

Additionally, it was necessary to control in our regression models for the number of ECT treatments. In our earlier paper ([@bib49]) we found a mild effect between hippocampus volume change and clinical response, but, counterintuitively, increased volume change was associated with worse outcomes. However, this relationship was completely absent when we controlled for the number of ECTs. We have previously demonstrated a dose-response relationship between hippocampal volume change and the number of ECT sessions ([@bib49]). Also, due to the naturalistic design, clinical outcome correlated with the number of ECT sessions: patients with the worse or slower response received more ECT treatments. Mediation analysis supported a very similar situation in our sample with p=0.035 and p=0.034 in L and R Hippocampus reflectively (Sobel test).

It was, therefore, necessary to control for the number of ECT sessions to avoid detecting spurious correlations between clinical response and volume change. Without an earlier, fixed mid-point assessment, we are unable to assess differences in rate of change, which could be relevant to specific depression subtypes ([@bib18]) and eventual clinical response. Notably, the overall volume changes measured in this study do not permit us to make conclusions about more structure-function relationships that might be better assessed with shape or hippocampal subfield analysis ([@bib55]; [@bib67]).

Finally, the volume change required for response may be non-linear. A minimum electric field of 30--40 V/m may be necessary to induce neuroplasticity. Increasing the electric field between 30--40 V/m and 100 V/m is related to a monotonic increase in hippocampal volume. Electric field above 100 V/m is still associated with hippocampal neuroplasticity but the dose-response relationship may be less robust and represent a ceiling effect of electric-field induced neuroplasticity as illustrated in [Figure 3](#fig3){ref-type="fig"}. Surpassing the neurpolasticity threshold (100 V/m) appears to be unrelated to further volumetric increases and antidepressant response. Thus, the relationship between e-field and volumetric changes may be conceptualized as a 'neuroplasticity threshold' between 30--40 V/m and 100 V/m. This thresholding effect also preserves the laterality of electric field and neuroplasticity. Our sample was limited to right unilateral electrode placement. In the left hippocampus, the maximum electric field is \~80 V/m ([Figure 3](#fig3){ref-type="fig"}) and below the 100 V/m 'ceiling effect' noted in the right hemisphere. Consequently, in our right unilateral sample, hippocampal electric field and related changes in neuroplasticity will demonstrate laterality effects.

Our findings indicate widespread and robust volume changes in both cortical and subcortical regions. The GEMRIC group recently published a comprehensive paper on a larger dataset with similar volumetric findings. The processing pipeline that was used has been validated against many commonly used tools for estimating longitudinal volume change ([@bib29]; [@bib28]). Specifically, it was previously compared head-to-head with FreeSurfer 5.3, and we have already repeated this comparison for data from one of the GEMRIC sites ([@bib48]). Our comparisons of power estimations based on results from the FreeSurfer longitudinal pipeline and Quarc (Table 3 in [@bib48]) were in line with those of the earlier publications. In agreement with previous research, the effect sizes show regional differences indicating that previous studies with smaller sample sizes were underpowered to detect cortical changes, and that can explain why they only found subcortical volume increase. Furthermore, using the same methodology, we did not find any significant volume change in the 95 healthy controls (received no ECT) who were imaged at two time points ([@bib50]).

We acknowledge several limitations that influence result interpretation. First, our approach was agnostic to seizure duration, which may contribute to the effects of EF on regional volumes and clinical response. This investigation also does not preclude the possible role of seizure in both volume changes and clinical outcomes. However, the selection of right unilateral electrode placement subjects does attempt to disentangle the impact of the generalized seizure from the lateralized electric field. Second, the electric field models a single current pulse and ignores the temporal dynamics of stimulus (pulse-width, and frequency and duration of the pulse train) ([@bib64]; [@bib65]). Differences in pulse width, for example, may affect volume change and clinical outcomes. Furthermore, differences in maximal charge, unrelated to current amplitude, are different between the US and Europe (Europe permits twice the US maximal charge). The analysis included patients treated with one of two different ECT devices. We controlled for the differences in current related to the two devices with the electric field modeling (800mA for the spECTrum, 900mA for the Thymatron), but we are unable to control for other differences in stimulus delivery related to the device. Third, the study sites in this mega-analysis likely include heterogeneity in patient selection and other treatment related factors that were not controlled. Despite these site differences, the large sample size and additional inclusion criteria permitted whole brain analyses with electric field, and within-subject volume change and clinical outcomes. Finally, we did not assess cognitive correlates with electric field or volume change. General clinical experience and previous results from studies investigating electrode placement strategies indicate that ECT-mediated neurocognitive side effects are influenced by electrode placement ([@bib20]; [@bib56]; [@bib36]). Previous electric field studies on simulated head models have already shown that cognitive side effects might be attributed to the electric field spatial distributions associated with different electrode placements ([@bib4]; [@bib15]). These considerations would indicate that these volumetric changes might be associated with cognitive side-effects, but further studies are needed to confirm this relationship.

Conclusion {#s3-1}
----------

This investigation is the first demonstration that the ECT-induced electric field is related to increases in cortical and subcortical structures. These results support that the electric field, independent or synergistic with seizure activity and other stimulation parameters, can have a profound effect on the biology of the human brain. The electric path originates from the ECT electrode handle, which delivers a constant stimulus current from the scalp. From the scalp, the electric path travels through skin, skull, cerebral spinal fluid, and brain. Each tissue type has different conductive properties and abundant individual variability ([@bib16]). This variability creates different electric field doses despite the similar current at the scalp. These differences in current may lead to both differences in volume changes as well as clinical outcomes. In our investigation, the electric field-induced volume change in the bilateral amygdala and the left hippocampus suggests regional specificity, but the association of these volumetric changes with clinical outcomes remains elusive. Better controlled prospective trials are needed to answer if these robust volume changes and corresponding electric field distributions are associated with any clinical or cognitive consequences.

Materials and methods {#s4}
=====================

Participants {#s4-1}
------------

GEMRIC is a multi-site consortium focused on improving and individualizing ECT by researching the still elusive mechanisms of action and response-related biomarkers ([@bib48]). Patients in the GEMRIC database participated in clinical and imaging assessments pre- and post-ECT series. To control for the differential effects of electrode placement on electric fields, we only included subjects who received high-dose (six times the seizure threshold) right unilateral electrode placement throughout the ECT series. We screened 281 patients from 10 sites ([@bib49]), and data were included from 7 GEMRIC sites with the RUL only criteria (n = 151, 92 F, age: 57.5 ± 17.1, 12 with bipolar depression, 139 with major depression, demographic summary is in [Table 2A and B](#table2){ref-type="table"}). Depression severity was assessed with the Montgomery--Åsberg Depression Rating Scale (MADRS) ([@bib44]) or 17- or 24-item Hamilton Depression Rating Scale (HAM-D) ([@bib24]). For sites collecting only the 17- or 24-item HAM-D, a validated equation was used to convert the 17-item HAM-D to a MADRS score ([@bib27]). Clinical response was estimated as the percentage change of the MADRS scores (ΔMADRS = (MADRS~TP1~-MADRS~TP2~)/MADRS~TP1~). Although more conservative than absolute change or post-ECT depression outcomes ([@bib71]), the rationale for the use of the proportional change score was to control for the variability of the pre-ECT MADRS. The range of the number of sessions for the ECT series was between 7 and 20. Half of the subjects were medication free during the ECT series (n = 69). Concurrent pharmacotherapy for the remaining subjects was as follows: selective serotonin reuptake inhibitors (SSRI, n = 28), serotonin norepinephrine reuptake inhibitors (SNRI, n = 37), tricyclic antidepressants (TCA, n = 10), and no record of concurrent medications (n = 6). Only five subjects received medication changes during the ECT series (two medication free subjects started SSRI and TCA, one subject switched from SNRI to TCA, one from SNRI to TCA and one from SSRI to SNRI). The results did not change if we used medication status or diagnosis (bipolar or unipolar depression) as a nuisance variable in the linear models of this study. All sites' contributing data ([Table 2B](#table2){ref-type="table"}) received approval by their local ethical committees or institutional review board, and the centralized mega-analysis was approved by the Regional Ethics Committee South-East in Norway (2013/1032 ECT and Neuroradiology, June 1, 2015).

###### Clinical and demographics summary.

  --------------------------------------------------------------------------------------------------------------------------------------------
  [Table 2A](#table2){ref-type="table"} Overall Summary                                                                          
  ------------------------------------------------------- ----- ------------ ------------- ------------- ------ ---------------- -------------
  All                                                     151                57.5\         69,65,10,62   10.6   33.9             61.3
                                                                             (17.1)                                              

  Female                                                  92                 56.4 (18.4)   42,36,8,42    10.4   34.4             63.4

  Male                                                    59                 59.3\         27,29,2,20    10.9   33.3             58.1
                                                                             (14.7)                                              

  [Table 2B](#table2){ref-type="table"} Site Summary                                                                             

  Site                                                    N     Age (mean)   Age (sd)                           Baseline MADRS   Δ MADRS (%)

  1                                                       30    39.87        12.68                              40.73            45.12

  2                                                       33    64.48        8.93                               31.36            69.48

  3                                                       16    73.62        12.45                              29.56            77.24

  4                                                       23    46.87        9.19                               29.96            43.18

  5                                                       2     62.50        0.71                               36.75            32.03

  6                                                       18    48.50        16.77                              33.83            57.12

  7                                                       29    72.66        7.57                               35.07            79.13
  --------------------------------------------------------------------------------------------------------------------------------------------

^\*^med. free: medication free, SSRI: selective serotonin reuptake inhibitor, SNRI: serotonin and norepinephrine reuptake inhibitors, TCA: tricyclic antidepressants, AP: antipsychotic medications, there were not patients on MAO inhibitors.

Imaging {#s4-2}
-------

The image processing methods have been detailed previously ([@bib49]; [@bib48]). In brief, the sites provided longitudinal 3T T1-weighted MRI images (at baseline and after the end of the course of ECT) with a minimal resolution of 1.3 mm in any direction (detailed parameters in [Supplementary file 6](#supp6){ref-type="supplementary-material"}). The raw DICOM images were uploaded and analyzed on a common server at the University of Bergen, Norway. To guarantee reproducibility, in addition to the common platform, the processing pipelines were implemented in a docker environment ([@bib42]). First, images were corrected for scanner-specific gradient-nonlinearity ([@bib34]). Further processing was performed with FreeSurfer version 5.3, which includes segmentation of subcortical structures ([@bib22]) and automated parcellation of the cortex ([@bib17]). In addition to brainstem and bilateral cerebellum, this automated process identified 33 cortical and eight subcortical regions in each hemisphere. Altogether this resulted in 85 regions of interest (ROIs) ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Next Quarc ([@bib28]) was used for unbiased, within-subject assessment of estimation of longitudinal volume change (ΔVol - %) ([Figure 5](#fig5){ref-type="fig"}). In summary, we calculated bias-free estimation of volumetric change from 85 brain regions across the timespan of an ECT course in 151 individuals who received between 4 to 20 ECT sessions (1 ½ week to 2 month).

![Illustration of the methods.\
We analyzed longitudinal structural MRI data from 151 individuals. We calculated the volume change and the magnitude of electrical field in 85 regions across the human cortex and subcortical structures.](elife-49115-fig5){#fig5}

Electric Field modeling {#s4-3}
-----------------------

We estimated ECT-induced electric fields with Realistic Volumetric-Approach to Stimulate Transcranial Electric Stimulation (ROAST v1.1) ([@bib30]). After segmentation of the structural MRI T1-weighted images, ROAST builds a three-dimensional tetrahedral mesh model of the head. The segmentation identifies five tissue types: white and gray matter of the brain, cerebrospinal fluid, skull, and scalp, and assigns them different conductivity values: 0.126 S/m, 0.276 S/m, 1.65 S/m, 0.01 S/m, and 0.465 S/m respectively. ECT electrodes of 5 cm diameter were placed over the C2 and FT8 EEG (10--20 system) sites. Study sites from the GEMRIC database used either the Thymatron (Somatics, Venice, Florida, six sites, N = 121) or spECTrum (MECTA Corp., Tualatin, Oregon, one site, N = 30) devices. The electric field was solved using the finite-element method with unit current on the electrodes and, subsequently, it was scaled to the current amplitude of the specific devices (Thymatron 900 mA, spECTrum 800 mA). These procedures resulted in a voxel-wise electric field distribution map in each individual. We calculated the average electric field across the 85 three-dimensional ROIs in every individual ([Figure 5](#fig5){ref-type="fig"}) based on the Freesurfer parcellations and segmentations. The voxel values with the top and lowest one percentile in each ROI were omitted during calculations to reduce boundary effects.

Statistical analysis {#s4-4}
--------------------

### Laterality of electric field and volume change {#s4-4-1}

Our statistical analysis was performed in R ([@bib53]), and the underlying analyses can be found at <https://github.com/argyelan/Publications/> (copy archived at <https://github.com/elifesciences-publications/Publications-1>) in org mode ([@bib59]). We first calculated the effect sizes (Cohen's d) for longitudinal volume changes in each region. We assessed the correlations between the average electric fields and the effect sizes of volume changes across all the 85 regions. We further explored the hemispheric differences by calculating the pair-wise difference in volume changes across the corresponding ROIs (42 pairs). We defined the laterality index as the effect size of the pair-wise difference for both EF and ΔVol among homotopic ROIs. We then assessed the correlations between laterality indices of EF and ∆Vol across the 42 pairs of regions.

Electric field and volume change {#s4-5}
--------------------------------

We assessed the relationship between EF and ∆ Vol with the following linear mixed effect model in all 85 regions: 1) ΔVol \~EF + Age + number of ECT sessions + site (where EF, age, and number of ECT sessions were fixed effects, and site was random effect, while the dependent variable was volume change). Age, number of ECT sessions, and site, considered as nuisance variables, were included based on our prior observations of an inverse relationship between ECT session number and response ([@bib49]). Further, age is also shown to impact clinical response (older patients have increased probability of response, in our sample: t = 5.75, df = 149, r = 0.43, p\<10^−7^) and age-related changes on brain structure are related to EF ([@bib16]). We used Benjamini and Hochberg false discovery rate (FDR) correction method ([@bib5]) to control for multiple comparisons across 85 ROIs, where a conservative FDR -corrected p\<0.01 was chosen as the statistical threshold of significance.

Electric field, volume change, and clinical response {#s4-6}
----------------------------------------------------

We assessed the relationship between ∆MADRS and EF and ∆ Vol with the following linear mixed effect model in all 85 regions: 1) ΔMADRS \~ ΔVol + Age + number of ECT sessions + site; and 2) ΔMADRS \~EF + Age + number of ECT sessions + site (site as random effect). We used the same Benjamini and Hochberg FDR correction for multiple comparison corrections. In addition to analyzing the percentage change of the clinical response, we also evaluated the same models with absolute changes, using baseline MADRS as a covariate. We provided the results of these analyses in the second half of the corresponding Supplementary Files.
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Additional files {#s6}
================

###### Once EF and ΔVol were collected across 85 ROI in 151 subjects, all the rest of the calculations were carried out in R environment.

This file is the source code of these calculations organized in org-mode (<https://orgmode.org/>) for reproducibility.

###### Volume changes following electroconvulsive treatment (ECT).

One sample t-test in each ROIs. The table indicates t, uncorrected p, Cohen's d effect size, and FDR corrected p values. This sample is a sub-cohort of a recent publication of 331 subjects ([@bib50]). In contrast with that publication we included patients with RUL only electrode placement.

###### The laterality of volume changes after RUL ECT.

The table contains the results of 42 pairwise t-tests between the volume changes of the right and the left side of the corresponding regions. The table indicates t, uncorrected p, mean, Cohen's d effect size and FDR corrected p values.

###### The relationship between clinical response and volume change across individuals.

The table indicates the t values of the corresponding clinical covariates modeled as fixed effects: volume change, age, and number of ECT.

###### The relationship between clinical response and electric field across individuals.

The table indicates the t values of the corresponding clinical covariates modeled as fixed effects: electric field, age, and number of ECT.

###### The relationship between the baseline volume and age across 85 ROIs.

###### MRI summary.

The table indicates the parameters of the structural image acquisition across sites.

Data availability {#s7}
=================

Source data files (.csv) including processed data have been provided for Figures 1--4, Figure 3---figure supplement 1 and Figure 4---figure supplement 1. Raw data cannot be made available publicly because we do not have consent or ethical approval for this and the data cannot be anonymised. The data are stored on a secure centralized server at the University of Bergen, Norway. Participating GEMRIC sites have access to the raw data according to specific data policy and safety rules of the consortium, and in accord with the approval from the ethical committee. The GEMRIC consortium welcomes new members who are interested in the neuroimaging research of ECT. We hold board meetings twice a year when new members can apply to join and gain access to the database available on the GEMRIC servers. For more about the application process please visit <https://mmiv.no/how-to-join-gemric/> or write to Leif Oltedal (leif.oltedal\@uib.no). General information about the consortium can be found on the following website: <https://mmiv.no/gemric/>. For transparency and reproducibility, the entire analytical approach is uploaded to the <https://github.com/argyelan/Publications/tree/master/ECTEFvsVOLUME> (R scripts in org mode), and also was uploaded to eLife.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This analysis of data from the GEMRICS consortium on electroconvulsive therapy (ECT) investigates the potential links between electric field, brain volume change, and antidepressant response. Using data from 151 patients, the study finds a significant volume increase in the large majority of brain regions examined and a significant relation between electric field and volume change, particularly in left hippocampus and left amygdala. By contrast, it fails to find a significant relation between either electric field or volume change and clinical response. Given the importance of ECT as a last resort for treating severe depression and the necessity of better understanding its mechanisms, this study contributes important biological findings that will guide future investigations on the mechanisms of ECT.

**Decision letter after peer review:**

Thank you for submitting your article \"Electric field causes volumetric changes in the human brain\" for consideration by *eLife*. Your article has been reviewed by two peer reviewers, including Klaas Enno Stephan as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Christian Büchel as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Juergen Dukart (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This paper reports an analysis of data from the GEMRICS consortium on electroconvulsive therapy (ECT), investigating the potential links between electric field, brain volume change, and antidepressant response. Using data from 151 patients, the study finds a significant volume increase in 82 of 85 brain regions examined and a significant relation between electric field and volume change in left hippocampus and left amygdala. By contrast, it fails to find a significant relation between either electric field or volume change and clinical response.

Given the importance of ECT as a last resort for treating severe depression and the necessity of better understanding its mechanisms, this study addresses a highly relevant and timely issue. Both reviewers were generally positive about this paper. However, they also identified several issues that would require revisions and additional analyses.

Essential revisions:

1\) It did not get entirely clear to me whether overlapping questions (or perhaps even the same) have been asked in previous analyses using data from the GEMRICS consortium. I do not necessarily consider this a problem, as long as the data are different, but it should be transparent for the reader.

2\) Results section: the descriptions of the findings in Figure 4 (i.e., the alleged ceiling effect in the right hemisphere) are rather cryptic in the main text and deserve more explanation. I also wondered whether the difference between volume changes in left and right hemisphere (the right panel of Figure 4) is actually significant? Also, it would be helpful if you could comment on how this putative ceiling effect is compatible with the findings presented in Figure 3.

3\) The central findings reported in the subsection \"Electric field, volume change, and clinical response\" would deserve a considerably more detailed description. There are no space constraints in *eLife*, and it would be helpful to see a detailed breakdown of the statistical analyses in the main text (not just in the supplementary material). In particular, it would be nice to see the relative influence of each component of the regression model. For example, one would like to see in the main text how strong the effect of age was on clinical response to ECT.

4\) The authors used% changes in MADRS as the outcome. This choice is problematic as a reduction from 2 to 1 point is a 50% reduction whilst a reduction from 40 to 30 is only 25%. This choice may therefore create quite a biased evaluation of clinical improvement. The authors are therefore advised to repeat the analyses using the absolute scores as more unbiased measurement of clinical response.

5\) In the model evaluating the effects of volume change on MADRS the authors also include number of ECT sessions as a covariate. This is problematic from a conceptual point of view. The authors aim to study the mediating effect of volume changes induced by ECT on clinical symptoms. Controlling for the number of ECT sessions removes exactly this variance of interest from volume changes. The authors should therefore repeat the analyses without adjusting for this covariate, or perhaps even more convincingly, perform a mediation analysis that disentangles the direct and indirect (via volume changes) effects of number of ECT sessions on MADRS scores. Similar concern applies to age as a mediator of the effect of ECT.

6\) Please add a more detailed description of the overall cohort (i.e. sex, medication status....) to Table 1A, also not only per site but for the whole cohort and move it to the main body as it is important for a clinical study to have this information in the main body.

7\) At least some studies suggest potentially differential relationship between volume changes upon ECT and clinical response in bipolar and unipolar depression. Whilst the bipolar group may be not large enough it makes sense to test for this relationship separately for both diagnostic groups, or at least for major depression.

8\) Lastly, I am concerned by the highly significant volume increases in basically all brain regions in both hemispheres reported in Supplementary file 2 (excluding only the cerebellum). These effects go basically against all previous studies reporting rather quite specific structural changes upon ECT. The authors seem to use some very specific and a rather uncommon software package to compute these changes which raises the question of a methodological issue with the respective software. As the authors already have the free surfer estimates, I would ask them to compute directly the volume changes from those just to confirm that the effects are not dependent on the respective software choice.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Electric field causes volumetric changes in the human brain\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Christian Büchel (Senior Editor) and Klaas Enno Stephan (Reviewing Editor).

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

Point 4: In your response, you referred to a \"complementary analysis with baseline MADRS score as a covariate\" which \"resulted in similar findings to our% MADRS.\" We may have overlooked this but failed to find this analysis. We would like to ask that this complimentary analysis is included in the main text (or in the supplementary material, with a direct reference in the main text) so that reviewers and readers can see the similarities directly.

Point 5: Given that this is a question many readers may wonder about, it would be worth to include your detailed explanations (why no mediation analysis was performed and why \"number of ECT sessions\" was included as a covariate in the statistical model) in the Discussion section of the paper.

Point 8: We would suggest that the previous validation of the analysis pipeline against other software packages is described in the Discussion section of the paper, together with your interpretation why previous studies failed to find widespread volume changes, in order to make this issue transparent.
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Author response

> Essential revisions:
>
> 1\) It did not get entirely clear to me whether overlapping questions (or perhaps even the same) have been asked in previous analyses using data from the GEMRICS consortium. I do not necessarily consider this a problem, as long as the data are different, but it should be transparent for the reader.

The EF modeling data has not been included in previous GEMRIC analyses; the analysis of EF modeling with volume change (the main finding) and clinical response is completely new. It is correct that the broad distribution of volume change and relation to clinical response was described in more detail in a separate recent GEMRIC paper (Ousdal et al., 2019). However, that analysis also included patients stimulated with bilateral electrode placements. The present investigation includes only subjects treated with right unilateral electrode placement and e-field analysis. We have clarified the differences with the current work from previous work as follows in the concluding sentence of our Introduction: "For the purpose of our primary research question and in contrast to previous GEMRIC investigations, we limited the analyses to subjects that only received right unilateral electrode placement."

> 2\) Results section: the descriptions of the findings in Figure 4 (i.e., the alleged ceiling effect in the right hemisphere) are rather cryptic in the main text and deserve more explanation. I also wondered whether the difference between volume changes in left and right hemisphere (the right panel of Figure 4) is actually significant? Also, it would be helpful if you could comment on how this putative ceiling effect is compatible with the findings presented in Figure 3.

We have added to our Discussion section to further explain the non-linear relationship between EF and ∆Vol as follows: "Finally, the volume change required for response may be non-linear. A minimum electric field of 30-40 V/m may be necessary to induce neuroplasticity. Increasing the electric field between 30-40 V/m and 100 V/m is related to a monotonic increase in hippocampal volume. Electric field above 100 V/m is still associated with hippocampal neuroplasticity but the dose-response relationship may be less robust and represent a ceiling effect of electric-field induced neuroplasticity as illustrated in Figure 4. Surpassing the neurpolasticity threshold (100 V/m) appears to be unrelated to further volumetric increases and antidepressant response. Thus, the relationship between e-field and volumetric changes may be conceptualized as a "neuroplasticity threshold" between 30-40 V/m and 100 V/m. This thresholding effect also preserves the laterality of electric field and neuroplasticity. Our sample was limited to right unilatleral electrode placement. In the left hippocampus, the maximum electric field is \~ 80 V/m (Figure 3) and below the 100 V/m "ceiling effect" noted in the right hemisphere. Consequently, in our right unilateral sample, hippocampal electric field and related changes in neuroplasticity will demonstrated laterality effects."

The difference in right and left hippocampal volume changes (right panel of Figure 4) is signficant (t = 7.76, df = 150, mean difference = 0.011, p \< 0.0001). We have changed the Figure text for more clarity.

Figure 3 demonstrates laterality differences in EF and ∆Vol (upper panel) as well as the relationship between laterality between EF/∆Vol (lower panel). We have added to our Discussion section to furhter describe this relationship as noted above.

> 3\) The central findings reported in the subsection \"Electric field, volume change, and clinical response\" would deserve a considerably more detailed description. There are no space constraints in eLife, and it would be helpful to see a detailed breakdown of the statistical analyses in the main text (not just in the supplementary material). In particular, it would be nice to see the relative influence of each component of the regression model. For example, one would like to see in the main text how strong the effect of age was on clinical response to ECT.

We agree with this suggestion, so we made the following changes:

a\) We moved Supplementary file 4, which is our main finding, to Table 1, making the relative influence of the covariates more transparent. Also we extended the previous paragraph as follows: "Age was a necessary covariate since it was a confound in our model: both the spatial distribution of EF and volume changes correlate with age (30). We add number of ECT as a covariate to the model to be able to compare the relative influence of EF and number of ECT on volume change. In both left hippocampus and amygdala the effect size of EF was the largest (hippocampus: t~EF~ = 4.5, t~Age~ = -2.7, t~ECTnum~ = 3.3, amygdala: t~EF~ = 3.9, t~Age~ = -1.1, t~ECTnum~ = 2.1; Table 1)."

b\) We also extended subsection "Electric field, volume change, and clinical response" with more details: "Results indicated that none of the volume changes across the 85 ROIs had a significant relationship with clinical response (Supplementary file 4, hippocampus: t~ΔVOL~ = 0.2, t~Age~ = 5.4, t~ECTnum~ = -2.7, amygdala: t~ΔVOL~ = 0.1, t~Age~ = 5.6, t~ECTnum~ = -3.0). These results therefore contradicted the hypothesis that EF by increasing brain volume indirectly exerts its effect on clinical response, given the negative results between the volume change (mediator) and MADRS change (outcome). Testing the direct effect of the EF, we failed to find significant correlations between EF and clinical response (Supplementary Table 5, hippocampus: t~EF~ = 1.2, t~Age~ = 5.7, t~ECTnum~ = -3.0, amygdala: t~EF~ = 1.1, t~Age~ = 5.7, t~ECTnum~ = -3.0). Similar to earlier studies, age strongly correlated with both clinical response (32, 33, also see Clinical Results) and EF distribution (30), therefore we controlled for age in our model. The rationale for including the number of ECT treatments as covariate needs more explanation. Due to the naturalistic nature of the design, where most sites followed the patient until response or site-determined criteria for ECT discontinuation, we observed a negative relationship between clinical response and the number of ECT treatments. Not controlling for this variable could lead to spurious correlation between volume change and clinical response (for more on this see Oltedal et al., 2018 (3))."

c\) For more detailed rationale for controlling these covariates please see our discussion under point 5.

d\) We would like to also note that in the beginning of the Results section we have already explicitly stated the relationship between age and clinical response: "Highly significant correlations between age and clinical response (t = 5.75, df = 149, r = 0.43, p \< 10^-7^, older patients responded better)."

> 4\) The authors used% changes in MADRS as the outcome. This choice is problematic as a reduction from 2 to 1 point is a 50% reduction whilst a reduction from 40 to 30 is only 25%. This choice may therefore create quite a biased evaluation of clinical improvement. The authors are therefore advised to repeat the analyses using the absolute scores as more unbiased measurement of clinical response.

Based on these suggestions we used absolute scores in a complementary analsyis with baseline MADRS score as a covariate to control for baseline severity, and it resulted in similar findings to our% MADRS.

All subjects had a severe depressive episode (mean pre-ECT MADRS \~ 33.9). The rationale for modeling proportional change instead of absolute change score or outcome severity directly was to control for the pre-ECT MADRS variability. We added the following test (and reference) to our methods section: "Although more conservative than absolute change or post-ECT depression outcomes (Vickers, 2001), the rationale for the use of the proportional change score was to control for the variability of the pre-ECT MADRS."

> 5\) In the model evaluating the effects of volume change on MADRS the authors also include number of ECT sessions as a covariate. This is problematic from a conceptual point of view. The authors aim to study the mediating effect of volume changes induced by ECT on clinical symptoms. Controlling for the number of ECT sessions removes exactly this variance of interest from volume changes. The authors should therefore repeat the analyses without adjusting for this covariate, or perhaps even more convincingly, perform a mediation analysis that disentangles the direct and indirect (via volume changes) effects of number of ECT sessions on MADRS scores. Similar concern applies to age as a mediator of the effect of ECT.

We agree that mediation analysis would be the most interesting part of this dataset as it could support mechanistic understanding. Mediation analysis in general means that the following three conditions are met: (1) there is a significant correlation between outcome and mediator, (2) there is a significant correlation between predictor and outcome, and (3) in a multiple regression model where we model outcome\~mediator + predictor the mediator's coefficient remain significant, and at the same time the predictor's coefficient is not significant anymore. The reviewer is correct that our original goal was to show that volume change is the mediator of the clinical effect. Our original hypothesis was that EF -\> volume change -\> clinical response. (-\> means: cause) However, since volume change has no correlation with clinical change, neither in this dataset, nor in the recently published larger set of data with more heterogeneous ECT electrode placement (1), the first condition of mediation analysis is already invalid. Therefore, formal mediation analysis (i.e. Sobel test) is not appropriate for this dataset. In regard of the number of treatments we agree with the reviewer that careful consideration is required in adding the number of ECT treatment variable (see rationale under point 3). Here we provide extra details. Due to the naturalistic design, where most sites followed the patient until response or site-determined criteria for ECT discontinuation, "Number of ECT" could either be a mediator ([Author response image 1](#respfig1){ref-type="fig"}, Model 1) or a confound ([Author response image 1](#respfig1){ref-type="fig"}, Model 2). Regardless of the role of "Number of ECT" as mediator or confound, we believe that inclusion in our model is necessary because of the naturalistic, multi-site design of our dataset. The remaining correlation can reflect the direct relationship between volume change and MADRS change.
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In our earlier paper (Oltedal et al., 2018) we already encountered this problem because of this relationship between number of ECT and clinical response. Originally, we found a mild effect between hippocampus change and clinical response, but, contra-intuitively, number of ECT treatments reflected increased volume change that was associated with worse outcome (Oltedal et al., 2018). However, this relationship was completely absent when we controlled for the number of ECTs. This can be demonstrated via mediation analysis similar to which the reviewer proposed. Mediation analysis in our sample resulted in p = 0.035 and p = 0.034 in L and R Hippocampus reflectively (Sobel test). These results indicate that the relationship between clinical response and volume change in these areas are fully mediated via number of ECT sessions, therefore we should control for it in subsequent analyses.

> 6\) Please add a more detailed description of the overall cohort (i.e. sex, medication status....) to Table 1A, also not only per site but for the whole cohort and move it to the main body as it is important for a clinical study to have this information in the main body.

We added a new Table to the main text that contains the required clinical and demographic information.

> 7\) At least some studies suggest potentially differential relationship between volume changes upon ECT and clinical response in bipolar and unipolar depression. Whilst the bipolar group may be not large enough it makes sense to test for this relationship separately for both diagnostic groups or at least for major depression.

We have tested this hypothesis, however it did not change the results if we excluded the 12 bipolar patients from our sample. We inserted the following test in the manuscript: "The results did not change if we used medication status or diagnosis (bipolar or unipolar depression) as nuisance variables in the linear models of this study."

> 8\) Lastly, I am concerned by the highly significant volume increases in basically all brain regions in both hemispheres reported in Supplementary file 2 (excluding only the cerebellum). These effects go basically against all previous studies reporting rather quite specific structural changes upon ECT. The authors seem to use some very specific and a rather uncommon software package to compute these changes which raises the question of a methodological issue with the respective software. As the authors already have the free surfer estimates, I would ask them to compute directly the volume changes from those just to confirm that the effects are not dependent on the respective software choice.

The processing pipeline that was used has been validated against many commonly used tools for estimating longitudinal volume change (Holland and Dale, 2011; Holland, McEvoy and Dale, 2012. Specifically, it was previously compared head-to-head with FreeSurfer 5.3, and we have already repeated this comparison for data from one of the GEMRIC sites (Oltedal et al., 2017). Our comparisons of power estimations based on results from the FreeSurfer longitudinal pipeline and Quarc (Table 3 in Oltedal et al. 2017) were in line with those of the earlier publications. The broad distribution of volume change is described in more detail in a separate recent GEMRIC paper (Ousdal et al., 2001) and was already noted in terms of effect sizes in Figure 3 in Oltedal et al., 2017, see response to question 1. In agreement with previous research, the effect sizes show regional differences indicating that earlier studies with lower sample sizes were underpowered to detect cortical changes, and that can explain why they only found subcortical volume increase.

Furthermore, using the same methodology, we did not find any significant volume change in the 95 healthy controls (received no ECT) who were imaged at two time points (Osudal et al., Supplementary Table 4).

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> Point 4: In your response, you referred to a \"complementary analysis with baseline MADRS score as a covariate\" which \"resulted in similar findings to our% MADRS." We may have overlooked this but failed to find this analysis. We would like to ask that this complimentary analysis is included in the main text (or in the supplementary material, with a direct reference in the main text) so that reviewers and readers can see the similarities directly.

We have included these results in the second half of the Supplementary file 3 and Supplementary file 4. It is now indicated in the Materials and methods section: "In addition to analyzing the percentage change of the clinical response, we also evaluated the same models with absolute changes, using baseline MADRS as a covariate. We provided the results of these analyses in the second half of the corresponding Supplementary files."

> Point 5: Given that this is a question many readers may wonder about, it would be worth to include your detailed explanations (why no mediation analysis was performed and why \"number of ECT sessions\" was included as a covariate in the statistical model) in the Discussion section of the paper.

We have included two paragraphs in the Discussion section:

"Our original hypothesis was that a) local electric field had a causal role in clinical outcome and that b) the corresponding volume change was mediating this relationship \[...\] However, since volume change showed no correlation with clinical change, neither in this dataset, nor in the recently published broader dataset with more heterogeneous ECT electrode placement (10), only the first half of this model, namely that electric field strength was associated with volume change, was supported by our data."

"Additionally, it was necessary to control in our regression models for the number of ECT treatments. \[...\] Mediation analysis supported a very similar situation in our sample with p = 0.035 and p = 0.034 in L and R Hippocampus reflectively (Sobel test).

It was, therefore, necessary to control for the number of ECT sessions to avoid detecting spurious correlations between clinical response and volume change."

> Point 8: We would suggest that the previous validation of the analysis pipeline against other software packages is described in the Discussion section of the paper, together with your interpretation why previous studies failed to find widespread volume changes, in order to make this issue transparent.

We have included the following paragraph:

*"*Our findings indicate widespread and robust volume changes in both cortical and subcortical regions. \[...\] Furthermore, using the same methodology, we did not find any significant volume change in the 95 healthy controls (received no ECT) who were imaged at two time points (10)*".*
